A global survey of adverse event following immunization surveillance systems for pregnant women and their infants

Human Vaccines and Immunotherapeutics

Volumn 12, Issue 8, 2016, Pages 2010-2016

  Cassidy, Christine ^a   MacDonald, Noni E ^b,c   Steenbeek, Audrey ^a,c   Ortiz, Justin R ^d   Zuber, Patrick L F ^d   Top, Karina A ^b,c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c IWK HEALTH CENTRE   (Canada)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

adverse event following immunization; neonate; pregnancy; surveillance; vaccination

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MENINGOCOCCUS VACCINE; TETANUS TOXOID; VACCINE;

ACTIVE IMMUNIZATION; ARTICLE; DESCRIPTIVE RESEARCH; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; HEALTH SURVEY; HUMAN; INCOME; INFANT; INFLUENZA VACCINATION; NEWBORN; PASSIVE IMMUNIZATION; PREGNANCY; QUALITATIVE ANALYSIS; VACCINATION; VACCINATION REACTION; ADVERSE EFFECTS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EPIDEMIOLOGICAL MONITORING; GLOBAL HEALTH; HEALTH CARE POLICY; IMMUNIZATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EPIDEMIOLOGICAL MONITORING; FEMALE; GLOBAL HEALTH; HEALTH POLICY; HUMANS; IMMUNIZATION; INFANT; INFANT, NEWBORN; PREGNANCY;

EID: 84976541277     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2016.1175697     Document Type: Article

References (28)

1. F.M.Munoz, J.A.Englund. Vaccines in pregnancy. Infect Dis Clin North Am 2001; 15:253-71; PMID:11301819; http://dx.doi.org/10.1016/S0891-5520(05)70278-6
2. H.Y.Chu, J.A.Englund. Maternal immunization. Clin Infect Dis 2014; 59:560-8; PMID:24799324; http://dx.doi.org/10.1093/cid/ciu327
3. Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women − Advisory Committee on Immunization Practices (ACIP). 2012. MMWR Morb Mortal Wkly Rep 2013; 62:131-5; PMID:23425962
4. Australian Government Department of Health. 4.12 Pertussis. Australian Immunization Handbook [Internet]. 2015 [cited 2016Jan11]. Available from:http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook10-home∼handbook10part4∼handbook10-4-12
5. Department of Health United Kingdom. Chapter 24:Pertussis. In:Immunisation against infectious diseases—‘The green book’ [Internet]. 2006 [cited 2016Jan11]. Available from:https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/424448/Green_Book_Chapter_24_Pertussis_v2_0_April_2015.pdf
6. J.Laenen, M.Roelants, R.Devlieger, C.Vandermeulen. Influenza and pertussis vaccination coverage in pregnant women. Vaccine 2015; 33:2125-31; PMID:25796339; http://dx.doi.org/10.1016/j.vaccine.2015.03.020
7. E.A.McCarthy, W.E.Pollock, L.Tapper, M.Sommerville, S.McDonald. Increasing uptake of influenza vaccine by pregnant women post H1N1 pandemic:A longitudinal study in Melbourne, Australia, 2010 to 2014. BMC Pregnancy Childbirth 2015; 15:15; PMID:25652361
8. H.Ding, C.L.Black, S.Ball, S.Donahue, D.Izrael, W.W.Williams, E.D.Kennedy, C.B.Bridges, P.J.Lu, K.E.Kahn, et al. Influenza vaccination coverage among pregnant women—United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep 2014; 63:816-21; PMID:25233283
9. P.Lambach, J.Hombach, J.R.Ortiz. A global perspective of maternal influenza immunization. Vaccine 2015; 33:6376-9; PMID:26319068; http://dx.doi.org/10.1016/j.vaccine.2015.08.036
10. C.Cassidy, N.E.MacDonald, A.Steenbeek, K.A.Top. Adverse event following immunization surveillance systems for pregnant women and their infants:A systematic review. Pharmacoepidemiol Drug Saf 2015; 24:361-7; PMID:25683692; http://dx.doi.org/10.1002/pds.3754
11. M.F.Gruber. Maternal immunization:US FDA regulatory considerations. Vaccine 2003; 21:3487-91; PMID:12850366; http://dx.doi.org/10.1016/S0264-410X(03)00357-8
12. A.Mitchell, C.Louik, C.Chambers, K.Jones, M.Schatz. Immunization surveillance systems for pregnant women:Letter to the editor. Pharmacoepidemiol Drug Saf 2015; 24:669; PMID:26053022; http://dx.doi.org/10.1002/pds.3784
13. Data World Bank. Countries and economy [Internet]. 2013 [cited 2016Jan11]. Available from:http://data.worldbank.org/country
14. World Health Organization. WHO regional offices [Internet]. WHO 2015 [cited 2016Jan11]. Available from:http://www.who.int/about/regions/en/
15. Centers for Disease Control and Prevention (CDC). Vaccine safety datalink 2014. [Internet]. 2014 [cited 2015April10]. Available from:http://cdc.gov/vaccinesafety/activities/VSD.html
16. B.Källén, P.Olausson. Vaccination against H1N1 influenza with Pandemrix® during pregnancy and delivery outcome:A Swedish register study. BJOG 2012; 119:1583-90; http://dx.doi.org/10.1111/j.1471-0528.2012.03470.x
17. X.F.Liang, L.Li, D.W.Liu, K.L.Li, W.D.Wu, B.P.Zhu, H.Q.Wang, H.M.Luo, L.S.Cao, J.S.Zheng, et al. Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China. N Engl J Med 2011; 364:638-47; PMID:21288090; http://dx.doi.org/10.1056/NEJMoa1008553
18. S.E.Haberg, L.Trogstad, N.Gunnes, A.J.Wilcox, H.K.Gjessing, S.O.Samuelsen, A.Skrondal, I.Cappelen, A.Engeland, P.Aavitsland, et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med 2013; 368:333-40; PMID:23323868; http://dx.doi.org/10.1056/NEJMoa1207210
19. Y.Zheteyeva, P.L.Moro, X.Yue, K.Broder. Safety of meningococcal polysaccharide-protein conjugate vaccine in pregnancy:a review of the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol 2013; 208:478.e1-6; PMID:23453881; http://dx.doi.org/10.1016/j.ajog.2013.02.027
20. Ecology Global Network. World birth and death rates [Internet]. 2011 [cited 2016Jan11]. Available from:http://www.ecology.com/birth-death-rates/
21. United Nations. Annual number of birth [Internet]. 2011 [cited 2016Jan11]. Available from:http://data.un.org/Data.aspx?d = SOWC&f = inID%3A75
22. J.E.Graham, A.Borda-Rodriguez, F.Huzair, E.Zinck. Capacity for a global vaccine safety system:the perspective of national regulatory authorities. Vaccine 2012; 30:4953-9; PMID:22658930; http://dx.doi.org/10.1016/j.vaccine.2012.05.045
23. A.Amarasinghe, S.Black, J.Bonhoeffer, S.M.Carvalho, A.Dodoo, J.Eskola, H.Larson, S.Shin, S.Olsson, M.R.Balakrishnan, et al. Effective vaccine safety systems in all countries:A challenge for more equitable access to immunization. Vaccine 2013; 31 Suppl 2:B108-14; PMID:23598471; http://dx.doi.org/10.1016/j.vaccine.2012.10.119
24. M.Graven, P.Allen, I.Smith, N.E.MacDonald. Decline in mortality with the belize integrated patient-centred country wide health information system (BHIS) with embedded program management. Int J Med Inf 2013; 82:954-63; http://dx.doi.org/10.1016/j.ijmedinf.2013.06.003
25. G.R.da Silva e Sá, L.A.B.Camacho, M.S.Stavola, X.R.Lemos, C.A.B.de Oliveira, M.M.Siqueira. Pregnancy outcomes following rubella vaccination:A prospective study in the state of Rio de Janeiro, Brazil, 2001–2002. J Infect Dis 2011; 204:S722-8; http://dx.doi.org/10.1093/infdis/jir408
26. Public Health England. Vaccination in pregnancy (VIP) [Internet]. 2010 [cited 2016Jan11]. Available from:https://www.gov.uk/vaccination-in-pregnancy-vip
27. World Health Organization. National pharmacovigilance centres [Internet]. 2015 [cited 2016Jan11]. Available from:http://www.who.int/medicines/areas/quality_safety/safety_efficacy/nat_centres/en/
28. World Health Organization. About medicines safety [Internet]. 2015 [cited 2016Jan11]. Available from:http://www.who.int/medicines/areas/quality_safety/safety_efficacy/en/